{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:10:45Z","timestamp":1790086245057,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.drugalcdep.2011.05.019","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:35:45Z","timestamp":1309394145000},"page":"e23-e29","source":"Crossref","is-referenced-by-count":33,"title":["A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence"],"prefix":"10.1016","volume":"119","author":[{"given":"Adam","family":"Bisaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfrid N.","family":"Raby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2009.06.100","article-title":"Memantine blocks sensitization to the rewarding effects of morphine","volume":"1288","author":"Aguilar","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100739","article-title":"The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans","volume":"157","author":"Bisaga","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(99)00107-6","article-title":"In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-d-aspartate (NMDA) antagonists","volume":"59","author":"Bisaga","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0020","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4088\/JCP.09m05080ecr","article-title":"Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment","volume":"71","author":"Brooks","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.58.8.755","article-title":"Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement","volume":"58","author":"Carroll","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.294.8.903","article-title":"Anesthesia-assisted vs. buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial","volume":"294","author":"Collins","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1064-1297.15.3.228","article-title":"The effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humans","volume":"15","author":"Collins","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-007-0775-2","article-title":"Memantine produces modest reductions in heroin-induced subjective responses in human research volunteers","volume":"193","author":"Comer","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents\u2014preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0050","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders\u2014Patient Edition (SCID-I\/P, Version 2. 0)","author":"First","year":"1995"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1369-1600.2008.00121.x","article-title":"Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls","volume":"14","author":"Haney","year":"2009","journal-title":"Addict. Biol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-007-0998-2","article-title":"Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia","volume":"196","author":"Harris","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1360-0443.2006.01369.x","article-title":"Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review","volume":"101","author":"Johansson","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11785-U","article-title":"Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man","volume":"195","author":"Kornhuber","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00132576-200211000-00006","article-title":"A pilot sudy of memantine effects on protracted withdrawal (syndrome of anhedonia) in heroin addicts","volume":"1","author":"Krupitsky","year":"2002","journal-title":"Addict. Disord. Their. Treat."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-4328(03)00044-5","article-title":"Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal","volume":"144","author":"Maldonado","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0160","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0075","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0022-3565(24)37720-1","article-title":"Effects of N-methyl-d-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm","volume":"286","author":"Medvedev","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0165","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0090","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0022-3565(24)36483-3","article-title":"Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-d-aspartate receptor antagonist, memantine","volume":"280","author":"Popik","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0091-3057(95)02163-9","article-title":"The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence","volume":"53","author":"Popik","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.npp.1300760","article-title":"Reinstatement of morphine-conditioned reward is blocked by memantine","volume":"31","author":"Popik","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00008877-200305000-00008","article-title":"Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice","volume":"14","author":"Popik","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","article-title":"Pharmacodynamics of memantine: an update","volume":"6","author":"Rammes","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.pnpbp.2004.05.038","article-title":"Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice","volume":"28","author":"Ribeiro Do Couto","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.brainresbull.2004.10.005","article-title":"NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference","volume":"64","author":"Ribeiro Do Couto","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0740-5472(02)00301-X","article-title":"Behavioral naltrexone therapy: an integrated treatment for opiate dependence","volume":"23","author":"Rothenberg","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(99)00431-8","article-title":"Low affinity NMDA receptor channel blockers inhibit initiation of intravenous morphine self-administration in naive mice","volume":"378","author":"Semenova","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0130","series-title":"Ionotropic Glutamate Receptors as Therapeutic Targets","first-page":"71","article-title":"Depression","author":"Skolnick","year":"2002"},{"key":"10.1016\/j.drugalcdep.2011.05.019_bib0135","series-title":"Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2010"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T20:42:50Z","timestamp":1741293770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0376871611002456"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.05.019","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}